How to Estimate the Cost of Point-of-Care CD4 Testing in Program Settings: An Example Using the Alere Pima™ Analyzer in South Africa
Autor: | Sydney Rosen, Bruce A. Larson, Buyiswa Ndibongo, Matthew P. Fox, Lawrence Long, Kathryn Schnippel |
---|---|
Jazyk: | angličtina |
Rok vydání: | 2012 |
Předmět: |
Program evaluation
Health Screening Cost estimate Operations research Science Policy Economics Cost-Benefit Analysis Point-of-Care Systems 030231 tropical medicine Sexually Transmitted Diseases lcsh:Medicine Health Care Sector HIV Infections Viral diseases Social and Behavioral Sciences Cost Effectiveness 03 medical and health sciences South Africa 0302 clinical medicine Health Economics Diagnostic Medicine Medicine Humans Mass Screening 030212 general & internal medicine Activity-based costing lcsh:Science Mass screening Multidisciplinary Cost–benefit analysis business.industry lcsh:R HIV HIV diagnosis and management Health Care Costs Service provider Test (assessment) CD4 Lymphocyte Count AIDS Technology Development Technical report Infectious diseases lcsh:Q Public Health business Research Article Test Evaluation |
Zdroj: | PLoS ONE PLoS ONE, Vol 7, Iss 4, p e35444 (2012) |
ISSN: | 1932-6203 |
Popis: | Integrating POC CD4 testing technologies into HIV counseling and testing (HCT) programs may improve post-HIV testing linkage to care and treatment. As evaluations of these technologies in program settings continue, estimates of the costs of POC CD4 tests to the service provider will be needed and estimates have begun to be reported. Without a consistent and transparent methodology, estimates of the cost per CD4 test using POC technologies are likely to be difficult to compare and may lead to erroneous conclusions about costs and cost-effectiveness. This paper provides a step-by-step approach for estimating the cost per CD4 test from a provider's perspective. As an example, the approach is applied to one specific POC technology, the Pima Analyzer. The costing approach is illustrated with data from a mobile HCT program in Gauteng Province of South Africa. For this program, the cost per test in 2010 was estimated at $23.76 (material costs = $8.70; labor cost per test = $7.33; and equipment, insurance, and daily quality control = $7.72). Labor and equipment costs can vary widely depending on how the program operates and the number of CD4 tests completed over time. Additional costs not included in the above analysis, for on-going training, supervision, and quality control, are likely to increase further the cost per test. The main contribution of this paper is to outline a methodology for estimating the costs of incorporating POC CD4 testing technologies into an HCT program. The details of the program setting matter significantly for the cost estimate, so that such details should be clearly documented to improve the consistency, transparency, and comparability of cost estimates. |
Databáze: | OpenAIRE |
Externí odkaz: |